USPTO 2015–2025 USPTO PatentsView US Corporation

ResMed Corp.

USPTO PatentsView assignee record — 434 granted patents across 51 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).

434
Total patents granted
51
CPC technology areas
25.8
Avg claims per patent
-86%
5-year filing velocity

Portfolio overview

ResMed Corp. has been granted 434 US utility patents between 2015 and 2025, placing ResMed Corp. at rank #1,013 across all assignees tracked by PlainPatent. This portfolio spans 51 distinct Cooperative Patent Classification (CPC) subclasses, averaging 25.8 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, ResMed Corp. is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 65.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 52 grants, compared with 382 in the 2015–2019 window — a -86% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. ResMed Corp.'s 25.8 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 51 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark ResMed Corp. against peers pursuing similar technology classes.

How does ResMed compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows ResMed holds 434 patents — placing it at rank #1,013 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

-20020406080100 20152016201720182019202020212022202320242025 14
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
ResMed Corp. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 83 19.1%
2016 74 17.1%
2017 88 20.3%
2018 86 19.8%
2019 51 11.8%
2020 1 0.2%
2021 3 0.7%
2022 9 2.1%
2023 13 3.0%
2024 12 2.8%
2025 14 3.2%

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Complex
Velocity Declining

Where it ranks

Overall rank by patents

#1,013

Across all tracked assignees

Innovation Score

65.1 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does ResMed Corp. hold?
ResMed Corp. holds 434 US granted patents filed between 2015 and 2025, spanning 51 technology areas.
What is ResMed Corp.'s Innovation Score?
ResMed Corp. has an Innovation Score of 65.1 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does ResMed Corp. focus on?
ResMed Corp.'s top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 311 patents. The company has filed patents in 51 CPC subclasses total.
Is ResMed Corp.'s patent filing rate increasing or decreasing?
ResMed Corp.'s recent filing velocity is -86% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for ResMed Corp.'s patents?
ResMed Corp.'s patents average 25.8 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the ResMed Corp. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope